Researchers from the University of Sydney found that common blood-thinning drugs, like heparin, can act as antidotes for cobra venom. Using CRISPR gene-editing, they discovered that heparin prevents venom-induced cell death. This breakthrough could lead to more affordable and accessible snakebite treatments worldwide.